USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $-0.78 | $-0.82 | $-0.70 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $0.00 | $0.00 | $0.00 |
Immunic's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 8 | $-0.78 | $-0.94 | $-0.55 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 8 | $-3.96 | $-4.34 | $-3.34 |
| Dec 2022 | 8 | $-3.64 | $-4.42 | $-2.47 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.78 | $-0.76 | $-0.78 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-3.96 | $-3.73 | $-3.80 |
| Dec 2022 | 0 / 0 | $-3.64 | $-3.70 | $-3.83 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 7 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 7 | $0.00 | $0.00 | $0.00 |
| Dec 2022 | 7 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $-0.78 | - | - |
| Aug 6, 2021 | Jun 2021 | $-0.67 | $-0.82 | -22.99% |
| May 6, 2021 | Mar 2021 | $-0.69 | $-0.81 | -18.82% |
| Feb 26, 2021 | Dec 2020 | $-0.60 | $-0.46 | 22.91% |
| Nov 5, 2020 | Sep 2020 | $-0.65 | $-0.70 | -8.24% |
| Aug 2, 2020 | Jun 2020 | $-0.73 | $-0.90 | -23.85% |
| May 8, 2020 | Mar 2020 | $-0.96 | $-0.79 | 17.28% |
| Mar 16, 2020 | Dec 2019 | $-0.76 | $-0.75 | 1.32% |
| Nov 7, 2019 | Sep 2019 | $-0.65 | $-0.82 | -26.15% |
| Aug 8, 2019 | Jun 2019 | $-0.68 | $-1.52 | -123.53% |
| Jun 21, 2019 | Mar 2019 | $-0.59 | $-8.69 | -1372.25% |
| Mar 4, 2019 | Dec 2018 | - | $-2.33 | - |
| Nov 7, 2018 | Sep 2018 | $-11.20 | $-11.20 | - |
| Aug 7, 2018 | Jun 2018 | $-13.20 | $-12.00 | 9.09% |
| May 8, 2018 | Mar 2018 | $-13.60 | $-13.60 | - |
| Mar 13, 2018 | Dec 2017 | $-12.40 | $-14.00 | -12.90% |
| Oct 25, 2017 | Sep 2017 | $-12.80 | $-12.00 | 6.25% |
| Aug 3, 2017 | Jun 2017 | $-14.13 | $-11.60 | 17.91% |
| May 9, 2017 | Mar 2017 | $-14.60 | $-15.60 | -6.85% |
| Mar 7, 2017 | Dec 2016 | $-0.35 | $-0.37 | -5.71% |
| Nov 3, 2016 | Sep 2016 | $-0.32 | $-0.32 | - |
| Aug 2, 2016 | Jun 2016 | $-0.33 | $-0.30 | 9.09% |
| May 9, 2016 | Mar 2016 | $-0.28 | $-0.31 | -10.71% |
| Mar 8, 2016 | Dec 2015 | $-0.42 | $-0.34 | 19.05% |
| Nov 5, 2015 | Sep 2015 | $-0.58 | $-0.51 | 12.07% |
| Jul 30, 2015 | Jun 2015 | $-0.62 | $-0.63 | -1.61% |
| May 12, 2015 | Mar 2015 | $-0.62 | $-0.62 | - |
| Mar 19, 2015 | Dec 2014 | $-0.58 | $-0.59 | -1.72% |
| Nov 13, 2014 | Sep 2014 | $-0.63 | $-0.59 | 6.35% |
| Aug 6, 2014 | Jun 2014 | $-22.02 | $-36.40 | -65.30% |
| May 29, 2014 | Mar 2014 | $-20.78 | $-979.60 | -4614.15% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 26, 2021 | Dec 2020 | $-2.86 | $-2.85 | - |
| Mar 16, 2020 | Dec 2019 | $-3.50 | $-11.78 | - |
| Mar 4, 2019 | Dec 2018 | $0.00 | $-39.13 | - |
| Mar 13, 2018 | Dec 2017 | - | $-53.20 | - |
| Mar 7, 2017 | Dec 2016 | - | $-1.30 | - |
| Mar 8, 2016 | Dec 2015 | - | $-2.10 | - |
| Mar 19, 2015 | Dec 2014 | - | $-1017.18 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $0.00 | - | - |
| Aug 6, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 6, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Feb 26, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 5, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 2, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 8, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 16, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 7, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 8, 2019 | Jun 2019 | - | $0.00 | - |
| Jun 21, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Mar 4, 2019 | Dec 2018 | $0.00 | - | - |
| Nov 7, 2018 | Sep 2018 | - | - | - |
| Aug 7, 2018 | Jun 2018 | - | - | - |
| May 8, 2018 | Mar 2018 | - | - | - |
| Mar 13, 2018 | Dec 2017 | - | $0.00 | - |
| Oct 25, 2017 | Sep 2017 | - | - | - |
| Aug 3, 2017 | Jun 2017 | - | - | - |
| May 9, 2017 | Mar 2017 | - | - | - |
| Mar 7, 2017 | Dec 2016 | - | - | - |
| Nov 3, 2016 | Sep 2016 | - | - | - |
| Aug 2, 2016 | Jun 2016 | - | - | - |
| May 9, 2016 | Mar 2016 | - | - | - |
| Mar 8, 2016 | Dec 2015 | - | - | - |
| Nov 5, 2015 | Sep 2015 | - | - | - |
| Jul 30, 2015 | Jun 2015 | - | - | - |
| May 12, 2015 | Mar 2015 | - | - | - |
| Mar 19, 2015 | Dec 2014 | - | - | - |
| Nov 13, 2014 | Sep 2014 | - | - | - |
| Aug 6, 2014 | Jun 2014 | - | - | - |
| May 29, 2014 | Mar 2014 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 26, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 16, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Mar 4, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Mar 13, 2018 | Dec 2017 | - | $0.00 | - |
| Mar 7, 2017 | Dec 2016 | - | $6.00K | - |
| Mar 8, 2016 | Dec 2015 | - | - | - |
| Mar 19, 2015 | Dec 2014 | - | - | - |
IMUX's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 8 analysts, the average EPS estimation for Immunic's next quarterly earnings is $-0.78, with a low EPS estimation of $-0.94, and a high estimation of $-0.59.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.78, the last 2 month trend is $-0.72, and the 3 month trend is $-0.73.
Based on 7 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Immunic's previous earnings date was Aug 6, 2021 for its fiscal quarter ended Jun 30, 2021.
IMUX's earnings per share (EPS) was $-0.82, missing the consensus analysts forecast of $-0.67 by -22.99%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 0.75%, and higher than the same period a year before (Jun 2020) by -8.89%.
Revenues were $0.00.
The company reported a net income of $-17.93M.Free cash flow for the quarter was $-29.02M , compared to $-12.96M last quarter and $-9.28M a year before.
IMUX ended the quarter with $1.02M in total debt, a decrease of -22.29% compared to the previous quarter, and an increase of 28.37% compared to the same quarter a year before.
Immunic's previous annual earnings date was Feb 26, 2021 for its fiscal year ended Dec 31, 2020.
IMUX's earnings per share (EPS) was $-2.85, beating the consensus analysts forecast of $-2.86 by -0.35% , and higher than the previous year's EPS (Dec 2019) by -75.80%.
Revenues were $0.00.
The company reported a net income of $-44.02M.
Immunic reported a free cash flow of $-46.27M for its fiscal year, compared to $-28.60M a year ago.
The company ended the fiscal year with $679.00K in total debt, an increase of 30.58% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
